The Catalyst Arrived: Record EPS, a 23.5% ROTCE, and an Investment-Banking Recovery That's Now in the Numbers — Upgrading to Outperform

Results vs. Consensus

Q3 2025 Scorecard

Year-Over-Year Comparison

Sequential Comparison

Quality of Beat

Revenue: The ~$1.5B revenue beat is the broadest-based of the year. Unlike Q2 — where trading carried the quarter and IB lagged — Q3 saw all three ISG businesses fire (IB +44%, Equity +35%, FICC +8%) alongside record Wealth and record IM AUM. Critically, the sequential lift came despite Q2 being a strong trading quarter; the QoQ +8.5% revenue gain is the investment bank reopening, not a low base.

Margins: A 67% firm efficiency ratio (69% YTD) and a 33.1% firm pre-tax margin are the proof of operating leverage. The deferred-comp plan was a 100bp headwind to the Wealth margin this quarter (up from ~70bp in Q2), so the 30.3% reported Wealth margin actually understates the underlying figure. Management was emphatic that 30% is "an output, not an input" — the result of investment dollars driving pre-tax-profit growth, not a managed target.

EPS: The $2.80 print and ~49% YoY EPS growth outran the 18.5% revenue growth by a wide margin — pure operating leverage amplified by a zero provision, a falling share count from the $1.1B buyback, and a clean tax rate. This is the highest-quality EPS beat in our coverage of the franchise: no below-the-line help of consequence, every incremental dollar traceable to client activity and cost discipline.

Segment Performance

Institutional Securities — $8.5B, the Standout, All Engines Firing

Institutional Securities revenue of $8,523M (+25.1% YoY) was the quarter's standout and the source of most of the upside surprise. Where Q2 was "two halves" with banking on the launchpad, Q3 was the launch: the Americas led year-over-year growth, clients were active in every region, and the segment produced "powerful operating leverage." The breadth is what differentiates this from a typical strong-trading quarter — banking, equities and FICC all contributed.

Investment Banking — $2.1B, the Recovery Is Now Broad-Based

This is the line that changes our rating. IB revenue of $2,108M (+44% YoY, +37% QoQ) was "one of the strongest quarters in recent years," and the composition is what matters: total underwriting was up over 50%, but the recovery is no longer a one-leg story. Advisory rose to $684M on higher completed M&A; equity underwriting surged ~80% to $652M as a reopened IPO market drew sponsor- and founder-led companies (record post-Labor-Day issuance in the Americas); and fixed-income underwriting reached $772M on higher non-investment-grade and IG loan issuance plus event-related lending commitments. Robust pipelines "translated into announcements."

"Whether we are entering a golden age in investment banking remains to be seen, but it has been now several years of chatter around green shoots, and now the flywheel is taking hold. It's happening across industry groups... across regions... against a generally more favorable regulatory backdrop." — Ted Pick, Chairman & CEO

Assessment: Last quarter we wrote that "a confirmed advisory/DCM inflection is the upgrade trigger." Advisory is up year-over-year on completed activity, DCM is up on issuance, and the IPO market — the keystone that reopens both the exit lane for sponsors and the currency for strategic M&A — is functioning. The recovery has converted from pipeline to print across all three IB lines. Management frames it as a multi-year, "up-and-to-the-right" cycle, and the pent-up supply of deals (held back by years of regulatory drag and private-market warehousing) supports that. This is the segment that re-rates the stock.

Equity — $4.1B, Another Record on Financing

Equity trading of $4,116M (+35% YoY) set another record, again led by prime brokerage as average client balances and financing revenue reached new highs. Cash was strong on higher global volumes; derivatives rose on activity and EMEA strength. Management again leaned on the global-scale argument and added a newer nuance — the cash business, long thought destined for full electronification, is now run as a "barbell" of best-in-class electronic execution plus high-touch research-driven service that monetizes the first real cross-strategy dispersion "in a generation."

"For the first time in a generation you have real dispersion amongst our clients, which means they are looking for intellectual capital. We can offer that... not just in the classic financing pie, but also across cash and derivatives." — Ted Pick, Chairman & CEO

Assessment: The financing core continues to build a higher base; it is the most recurring, least-volatile part of the trading complex and scales with client balances and market levels. Management was candid that a deleveraging event or sharp market drop would lower financing revenue — the honest caveat — but the structural share gains (global footprint, derivatives, high-touch cash) are real. We treat the equities run-rate as durably higher than a year ago, with cyclical upside on top.

Fixed Income — $2.2B, Stable as Ever

Fixed Income of $2,169M (+8.3% YoY) again printed in its now-familiar ~$2.2B zone. Micro (credit/securitized) rose on robust securitization and durable lending balances; commodities finished strong on North American power and gas including structured transactions; macro declined on lower FX volatility. The CEO singled out FICC's multi-quarter stability as evidence of management quality and a pillar of the firm's earnings-durability narrative.

Assessment: Unchanged from our Q2 view — FICC is ballast. A franchise that holds $2B+ across rate and volatility regimes lowers the beta of the whole institutional segment and deserves a better multiple than the market historically assigned MS's trading book.

Wealth Management — $8.2B, the 30% Margin Achieved

Wealth Management delivered record revenue of $8,234M (+13.3% YoY) at a 30.3% reported pre-tax margin — the long-stated target, reached, and understated by a 100bp deferred-comp drag. Asset-management revenue hit a record $4.8B on a record $2.65T fee-based asset base; transactional revenue of $1.3B rose 22% YoY ex-DCP on strong self-directed engagement (Power E*TRADE Pro). Net new assets of $81B (+27% YoY) were broad across all three channels, with the IPO market and the workplace funnel as standout contributors. Bank lending rose $5B sequentially to $173.9B, deposits grew to $398B, and NII increased to $2.0B with a "modest sequential gain" guided for Q4.

"Reported margins were a full 30%... We added $81 billion of net new assets and $42 billion in fee-based flows... I think we're just scratching the surface of what we've seen in workplace." — Sharon Yeshaya, CFO

The workplace flywheel is now outrunning its own framing: against a stated ~$60B/yr migration target (from a $300B multi-year pool), the firm is "already three quarters into it and exceeding those numbers on a full-year basis." Management also deepened the moat in-quarter — an expanded Carta partnership to service private-company founders across their full public/private journey, and a Zero Hash digital-assets partnership to build out a "full wallet" for 2026.

Assessment: Reaching 30% is a milestone, but the more important message is that management treats it as an output of continued investment, not a ceiling — leaving the door open to further drift higher as operating leverage compounds. The workplace-to-adviser-to-fee-based funnel is the single most durable growth engine in our coverage of the franchise, and the IPO market's reopening is a direct accelerant (newly-liquid founders bringing assets to MS). This segment is why MS deserves a premium multiple, and Q3 widened the case.

Investment Management — $1.7B, Record AUM, Parametric Scaling

Investment Management revenue of $1,651M (+13.5% YoY) reached a record $1.807T of AUM, with long-term net inflows of $16.5B — more than half driven by Parametric, supported by fixed income. The standout disclosure was a large third-party-adviser partnership: an external asset manager adopting Parametric's customized/tax-efficient overlay across its own book, a new and potentially repeatable "white-label"-style channel (though management flagged such wins will be lumpy). Liquidity/overlay services saw $24.8B of inflows; performance income was $117M on infrastructure, PE and real-estate gains.

Assessment: The Parametric third-party-adviser win is the most strategically interesting item in IM in several quarters — it extends a product proven in the Wealth channel into institutional/intermediary distribution, a larger TAM. IM remains the smallest segment, but its flow momentum and the Parametric optionality give it weight beyond its revenue line.

Key KPIs

Key Topics & Management Commentary

Overall Management Tone: The most confident posture of the year, but still hedged with cyclical honesty. The CEO's framing — "the capital markets flywheel is taking hold" — ran through the call, supported by a record print and a broad IB recovery, yet he repeatedly refused to declare a "golden age," flagging geopolitical and market-cycle risk and noting that financing revenue is "inextricably linked" to elevated asset prices. The least-resolved area was the durability question itself: management is bullish on a multi-year banking cycle while explicitly acknowledging windows could shut.

1. The Capital-Markets Flywheel and the Banking Cycle's Duration

The dominant theme was that a years-awaited investment-banking recovery has finally engaged, broad across industry groups and regions and reinforced by a more favorable regulatory backdrop and AI-driven consolidation pressure. Management sees pent-up deal supply — warehoused in sponsor portfolios and constrained by years of regulatory drag on large-cap M&A — that "has to come."

"The entire daisy chain... probably takes us back to something that feels like the mid '90s... The difference now is you need the full kit. You need the full global support." — Ted Pick, Chairman & CEO

Assessment: The bull case is a multi-year cycle in which only a handful of full-kit global banks capture the complex, cross-border mandates. MS is positioned for it and gaining share. The honest caveat — windows can shut on geopolitical or market shocks — is why we upgrade to Outperform rather than chase a higher conviction; the trajectory is up-and-to-the-right with real cyclical risk around it.

2. The 30% Wealth Margin: Output, Not Input

Pressed on whether 30% is now sustainable and could drift higher, the CEO reframed the metric entirely: it is the byproduct of investment dollars driving pre-tax-profit and revenue growth across the funnel, not a managed target. Continued investment in E*TRADE (Power Pro, deposits), digital assets, workplace and advisers is the input; the margin is the output.

"We had a reported number in a reasonably friendly environment that was, I believe, 30.3%. But that is an output, not an input. So the continued input is our investment dollars to drive PBT growth." — Ted Pick, Chairman & CEO

Assessment: This is the right way to think about it and a subtle bull signal: by declining to cap the margin, management implies operating leverage can push it higher in friendly environments. We model the high-20s/30% as a durable base with upside, not a peak.

3. Capital Deployment, the 250bp+ Buffer, and Regulatory Reform

With excess CET1 above 300bp (a ~340bp actual cushion, including an 80bp Fed CCAR reconsideration), management walked through its deployment hierarchy: dividend "sacrosanct" at $1.00 and growing; buyback opportunistic (and possibly at a "slightly higher cadence"); organic investment as the clear priority. The CFO detailed the moving parts of the buffer — pending CCAR model changes, Basel, G-SIB and a finalized SLR rule — that should, over time, let MS prudently lower a "buffer on a buffer" as regulatory uncertainty recedes.

"Two-fifty-plus feels like the way to say it... the actual number is three-forty. The implied buffer is there." — Ted Pick, Chairman & CEO

Assessment: A shrinking required buffer plus continued capital accretion is a quiet, multi-year EPS tailwind via buybacks and balance-sheet redeployment — and it is now partly de-risked (the 80bp CCAR refund is real, not promised). This strengthens the Outperform case beyond the cyclical IB story.

4. Organic vs. Inorganic: Strategy, Culture, Timing, Price

On whether the ~340bp cushion should fund faster growth, the CEO reaffirmed an organic-first bias — internal investment "clears the bar and checks the most boxes" — while laying out a disciplined four-test framework for any deal (strategy, culture, timing, price) and citing MS's track record (Smith Barney, Solium, E*TRADE, Eaton Vance). He warned explicitly of "winner's curse" and said the firm "won't put up a print for the sake of it."

"This firm has successfully integrated Smith Barney, Solium, E*TRADE, and Eaton Vance. But there is such a thing as winner's curse in the financial services space. And we were not about to make that mistake." — Ted Pick, Chairman & CEO

Assessment: The discipline protects shareholders from a value-destructive deal at full valuations and keeps the capital-return base case intact. A clear positive for the risk profile and consistent with the prior-quarter posture.

5. Equities Share Gains and the Financing Base

Questioning probed why MS keeps gaining equities share. The answer: sustained multi-year investment in platform, people and global regions (Asia and EMEA in particular), with prime-brokerage financing scaling on rising client balances and a barbell cash/derivatives model. Management was candid that financing revenue is "inextricably linked" to asset-price levels — a deleveraging event would compress it.

Assessment: Durable structural share gains with an honest cyclical caveat. We credit the higher financing base while sizing the cyclical risk; net positive for the trading multiple.

6. NII Inflection and the Natural Hedges

On Wealth NII, the CFO guided a "modest sequential gain" in Q4 even as the Fed cuts, and — while declining 2026 guidance — flagged "room for an inflection." The mechanism: growing lending balances (SBL, mortgages, new client participation) and the historical pattern that falling rates bring higher sweep balances, both offsetting spread compression.

"There is room for an inflection... the reason that you can have that outlook really has to do with the lending balances that we've seen and the consistent growth in lending balances." — Sharon Yeshaya, CFO

Assessment: This directly addresses our Q2 worry that rate cuts would pressure NII. The lending build and sweep dynamics are genuine natural hedges; NII looks more like a stable-to-growing line than a 2026 headwind. A meaningful de-risking of the bear case.

7. The Carta Partnership and the Private-Markets Funnel

Management detailed the expanded Carta relationship: originally a referral model (private companies routed to MS as they approached public markets, with conversions already realized this year), now extended to deliver MS's advice-based wealth services to founders throughout their private-to-public journey. It dovetails with Solium (workplace/equity plans) to deepen MS's grip on company founders and family offices from formation onward.

Assessment: This is the "integrated firm" thesis made concrete — capturing wealth relationships at the source (private-company founders) and shepherding them through IPO and into the adviser-led channel. It compounds the workplace flywheel and is a structural, not cyclical, advantage.

Guidance & Outlook

Morgan Stanley does not issue formal guidance, but the forward markers were notably more constructive than Q2. NII is guided to a "modest sequential gain" in Q4 (rate/loan/deposit-mix dependent), with management signaling room for a 2026 inflection. The Q4 tax rate was reiterated at ~24%. IB pipelines were described as strong "across all three regions," with the sponsor realization cycle (IPO exits feeding both advisory and underwriting) "already beginning to play out."

Implied setup: Nine-month EPS reached ~$7.53 (a ~$10 annualized run-rate) at a 9-month ROTCE around 20%, with the highest-return quarter (Q3) carrying momentum into a seasonally solid Q4. If the IB cycle holds and Wealth/IM keep compounding, the franchise is tracking a through-cycle ROTCE comfortably in the high-teens-to-20% range — above the consensus assumption embedded in the stock a year ago.

Guidance style: Confident on direction, disciplined on specifics. Management let a record print and a broad IB recovery carry the optimism while declining to extrapolate 2026 NII or call a cycle peak — characteristic understatement that keeps the bull case credible.

Analyst Q&A Highlights

The Sustainability of the Investment-Banking Recovery

The opening line of questioning probed whether the IB strength and backlog were durable and how the recovery's diversity compared to prior cycles. Management's answer was its most bullish of the year on direction — a flywheel taking hold across groups and regions — while declining to declare a "golden age."

Q: "Can you talk about the sustainability of these trends, maybe the... backlog in investment banking, the diversity, and how that compares to maybe prior periods?"
— Dan Fannon, Jefferies

A: "Whether we are entering a golden age in investment banking remains to be seen, but... now the flywheel is taking hold. It's happening across industry groups... across regions... the pipeline looks very good across all three regions. So we are optimistic... the investment banking product category over the next couple of years should be generally up-and-to-the-right."
— Ted Pick, Chairman & CEO

Assessment: Diversity is the key word — a recovery across groups and regions, not a single hot sector, is more durable. Management committed to a multi-year up-trend while keeping the geopolitical caveat. This exchange is the analytical core of our upgrade.

Is the 30% Wealth Margin Sustainable — and Could It Go Higher?

A recurring investor question asked whether the milestone 30% pre-tax margin is durable or could drift in either direction over the medium term. Management reframed the margin as a result of investment-driven growth rather than a managed target.

Q: "Do you think you've achieved a point where the 30% pretax margin is sustainable?... is the risk that the 30% is drifting higher, or moving lower in terms of when we think about the medium-term outlook?"
— Ebrahim Poonawala, Bank of America

A: "We're going to continue to put investment dollars into the system. Now whether that, with continued operating leverage, gets us to a number that is higher than 30 over time — let's see how it goes... that is an output, not an input."
— Ted Pick, Chairman & CEO

Assessment: Declining to cap the margin is itself a bullish tell. The implication is that in friendly environments operating leverage can push Wealth profitability past 30% — supporting a higher through-cycle earnings base than the market underwrites.

Deploying the ~340bp Excess Capital Faster

With over 300bp of excess CET1 and strong returns, questioning pressed whether MS could deploy capital faster — organically or inorganically — to broaden the platform and drive growth. The CEO reaffirmed an organic-first bias and a disciplined four-test deal framework.

Q: "Are there areas that you could deploy more capital at a higher pace into to drive growth?... whether it be organic or inorganic, that would just broaden the platform, make the company better, drive future growth."
— Glenn Schorr, Evercore

A: "The best uses of capital continue to be internal investment into the business and the integrated firm... in virtually every case... we feel we can do the build internally, organically... whether the inorganic ticks all four boxes — strategy, culture, timing, price."
— Ted Pick, Chairman & CEO

Assessment: The discipline is reassuring — no value-destructive deal-for-the-sake-of-it — and keeps dividends, buybacks and organic build as the base case. With a 340bp cushion and a shrinking required buffer, the capital-return runway is long.

Where Are We in the Capital-Markets Cycle?

An analyst asked management to size where the cycle stands — what inning, over- or under-earning. The CEO declined the usual economic-cycle framing, arguing this cycle is driven by pent-up deal supply and structural factors rather than a textbook macro setup, while explicitly naming the risks.

Q: "Can you size where we are in the capital market cycle? Like, what inning are we in? Are you over-earning, under-earning?"
— Mike Mayo, Wells Fargo

A: "I'm just not sure it's working that way this time. There is clearly pent-up supply of product... the regulatory [constraint] on large-cap M&A has also been an unnatural constraint... I don't think it's just blue sky, all boats steaming... will there be periods where the windows could well shut... Absolutely."
— Ted Pick, Chairman & CEO

Assessment: The refusal to call an inning is intellectually honest and, on balance, constructive — pent-up supply plus a structural large-cap M&A unlock is a multi-year tailwind, but the candor about window risk is why we underwrite Outperform with cyclical humility, not a price-target moonshot.

Can Institutional Securities Profitability Be Sustained?

The closing question asked bluntly whether the ~20%+ ISG returns and ~$2.1B IB quarter could persist, implying a consolidated ROTCE above 20%. Management tied the answer to asset-price levels and credit spreads while emphasizing the durability it has engineered into the businesses.

Q: "You did 20% ROTCE this quarter... can you sustain this type of profitability in institutional securities?... we are really in a sweet spot if you choose — markets businesses are also humming."
— Saul Martinez, HSBC

A: "If you have lower asset prices and deleveraging and credit spreads widen... markets businesses generally are going to perform less well... That having been said, we spent a lot of time doing everything we can to make sure that there is durability inside of these businesses... the performance of the fixed income business for the last whole bunch of quarters has been remarkably stable."
— Ted Pick, Chairman & CEO

Assessment: Management neither over-claims sustainability nor dismisses it — the honest answer is that markets revenue is asset-price-sensitive but more durable than in prior cycles (FICC stability, financing base, IB share gains). That is exactly the right risk frame for an Outperform: higher base, real cyclical beta.

What They're NOT Saying

1. 2026 NII guidance: The CFO explicitly deferred 2026 NII guidance "to 2026," offering only "room for an inflection." With NII a meaningful Wealth line into a rate-cutting cycle, the unwillingness to frame next year leaves a real swing factor unquantified — though the directional tone improved markedly from Q2.
2. A cycle-peak acknowledgment: Despite a record print and 23.5% ROTCE, management would not say whether the firm is over-earning. The repeated "windows could shut" hedging is candid, but it also avoids putting a number on how much of Q3's strength is cyclical versus structural.
3. The durability of the Parametric third-party-adviser win: Management called the large white-label-style partnership "lumpy" and declined to size the pipeline of similar deals — so the repeatability of the most interesting IM growth vector is left open.
4. Specific buyback acceleration: With a 340bp cushion, management said the buyback "may" run at a "slightly higher cadence" but committed to no figure — leaving the pace of capital return, the cleanest EPS lever, vague.
5. The DCP normalization path: The deferred-comp drag rose from ~70bp (Q2) to ~100bp (Q3) on the Wealth margin, with no forward shape given — relevant to anyone modeling the margin's trajectory above 30%.

Market Reaction

• Pre-print setup: MS closed at $155.34 on October 14, up ~23.6% YTD and +38.4% over the trailing twelve months, but roughly flat (-0.8%) over the prior 30 days — the stock had consolidated for a month just below its prior 52-week closing high of $161.16, coiling into the print.
• Reaction (BMO same-day): The stock gapped up ~4.9% at the open ($162.93), traded as high as $166.77 (+7.4%), and closed at $162.65, up 4.7% (+$7.31) on heavy volume of 13.7M (2.5x the 30-day average) — a new 52-week closing high. The S&P 500 was up ~0.4% on the day.

This is the opposite of Q2's "sell the news." A clean, broad record — with the one soft spot from last quarter (IB still down YoY) now resolved into a +44% surge — gave the market exactly the confirmation it lacked in July. The stock broke out of a month-long consolidation to a fresh high on 2.5x volume, the signature of a re-rating rather than a relief bounce. The intraday fade from +7.4% to +4.7% reflects some profit-taking into strength after a 38% twelve-month run, but the close at a new high on heavy volume says the market re-underwrote the earnings power. That price action is consistent with our upgrade: the catalyst arrived, and the tape agrees.

Street Perspective

Debate: Is the IB Recovery a Multi-Year Cycle or a Pull-Forward?

Bull view: IB +44% with all three lines firing, a reopened IPO market, pent-up sponsor supply and a deregulating large-cap M&A backdrop point to a multi-year, mid-1990s-style up-cycle in which full-kit global banks take share.

Bear view: Some of the surge is a pull-forward of deals delayed for years; markets at all-time highs and tight spreads are precisely the conditions that precede a window slamming shut, and a single geopolitical shock pauses the calendar.

Our take: The bull has the better structural argument — the breadth across regions and products, plus the IPO-exit-feeds-M&A flywheel, is not a one-quarter pull-forward. But the bear's window-risk is real, which is why we upgrade to Outperform on a higher, more durable base rather than extrapolate Q3 into a permanent run-rate.

Debate: Has the Stock Re-Rated Too Far at a New High?

Bull view: At ~16x a ~$10 annualized EPS and ~3.3x tangible book, MS is not expensive for a 23.5%-ROTCE franchise with a 30% Wealth margin, a multi-year IB cycle, and a shrinking capital buffer fueling buybacks — the through-cycle earnings base is higher than consensus.

Bear view: A fresh 52-week high after a 38% run prices in the good news; if ROTCE mean-reverts toward the high-teens as markets normalize, today's multiple looks full and the stock churns.

Our take: We side with the bull on the through-cycle earnings power. The market is still anchoring to a lower normalized ROTCE than the franchise is now demonstrating; as that anchor lifts, the multiple has room. This is the crux of the upgrade.

Debate: Is Regulatory Reform a Real Earnings Catalyst Now?

Bull view: The 80bp CCAR reconsideration is a concrete, realized benefit; a finalized SLR rule and Basel/G-SIB clarity would let MS prudently lower its buffer and redeploy capital into higher-return lending — a structural ROTCE lift.

Bear view: Most of the framework is still proposed; management itself said it would move "prudently." Pricing in a regulatory windfall before final rules is premature.

Our take: Unlike Q2, part of this is now de-risked — the CCAR refund is in the capital ratio. We give the remaining reform optionality real weight: it converts a narrative into a building cushion, and it underpins the capital-return leg of the Outperform.

Model Update Needed

Valuation framing: At a $162.65 reaction close, MS trades at ~3.34x tangible book ($48.64) and ~16x a ~$10 annualized EPS run-rate. That multiple is not cheap in absolute terms, but it is reasonable for a franchise demonstrating a 23.5% ROTCE with a structurally higher earnings base than the market has historically assigned. We see the path to outperformance as the market lifting its normalized-ROTCE anchor toward what the franchise is now printing — a re-rating that, combined with buyback-driven EPS growth and a multi-year IB cycle, supports double-digit total-return upside over the next twelve months.

Thesis Scorecard Post-Earnings

Overall: Thesis materially strengthened. The one "pending" pillar from our initiation — a confirmed IB recovery lifting ROTCE durably — converted decisively, and the chief bear point (NII pressure) is receding. The residual risk is the cyclicality of the very cycle that is now driving results, which we underwrite with humility.

Action: Upgrading to Outperform from Hold. We initiated at Hold in Q2 wanting proof the catalyst would land; Q3 delivered it across IB, ROTCE, the Wealth margin and capital. We would revisit only on evidence the IB cycle is rolling over (pipeline conversion stalling, IPO window closing) or a markets shock that compresses financing revenue — neither in view today.